Companies Making Headlines in Extended Trading

Palantir Technologies

• Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street’s expectations.
• Adjusted earnings of 13 cents per share came in line with the consensus estimate.
• Palantir reported $884 million in revenue, topping the $863 million forecast by analysts.

Vertex Pharmaceuticals

• The biotech stock dropped 2% on disappointing quarterly results.
• Adjusted earnings came in at $4.06 per share, below the $4.32 per share forecast by analysts.
• Revenue of $2.77 billion also missed analysts’ estimates for $2.85 billion.

Mattel

• Shares of the toymaker declined 2.5% after management paused its 2025 full-year guidance due to tariff uncertainty.
• First-quarter results topped analysts’ estimates.

Neurocrine Biosciences

• The maker of neurological drugs jumped 11% postmarket after first-quarter revenue of $572.6 million topped analyst estimates.
• Sales of Ingrezza, used to treat movement disorders, rose 8% year over year to $545 million.

Lattice Semiconductor

• The chip stock fell 3.8% after first-quarter earnings and revenue both were in line with consensus estimates.
• Lattice guided toward current-quarter revenue between $118.5 million and $128.5 million.

Hims & Hers Health

• The telehealth company dropped 1%.
• Guidance for second-quarter revenue came in lighter than expected.

Ford Motor

• The maker of F-series pickup trucks fell 2.7% after hours on first-quarter results.
• Ford estimated the net cost of higher tariffs on EBIT in 2025 at about $1.5 billion and withdrew forward guidance.

Clorox

• Shares of the cleaning products manufacturer fell 2.8%.
• Clorox posted adjusted earnings of $1.45 per share on revenue of $1.67 billion in the fiscal third quarter.

Diamondback Energy

• The energy stock advanced nearly 1% after reporting better-than-expected results.
• Diamondback earned $4.54 per share, excluding items, in the first quarter.